Evidence map›Paper›PMID 33815814›Full record

ArticleJFMS open reports

Kaitlin Hopke, Alyssa Meyers, Lisa Auckland, Sarah Hamer, David Florin, Alison Diesel, Adam Patterson

Open access · goldAbstract readCase Reports
In one paragraph

Article in JFMS open reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Biology · 2025
    Review
  4. The Beneficial Use ofAnimals : an open access journal from MDPI · 2025
    Review
  5. Analysis of US Marketed Artemisinin Supplements for Use in Dogs.Journal of veterinary pharmacology and therapeutics · 2025
    Article
  6. Article
  7. Article
  8. Possibility ofCurrent tropical medicine reports · 2022
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kaitlin HopkeDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Alyssa MeyersDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Lisa AucklandDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Sarah HamerDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
David FlorinIndependent Medical Entomologist, New York, USA.
Alison DieselDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Adam PattersonDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Texas A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

case summaryThis case report documents the clinical appearance, diagnosis and novel treatment of a central Texas cat with cutaneous leishmaniosis. The cat presented with a linear erosion on the right pinnal margin, an ulcerated exophytic nodule on the right hock and a swelling in the right nostril. Cytological and histopathological findings were consistent with leishmaniosis. PCR confirmed the presence of RELEVANCE AND NOVEL INFORMATION: This case report demonstrates endemic feline leishmaniosis in central Texas and provides the clinician with alternative therapeutic options for medical management.

Indexed as

artemisinincutaneous leishmaniosisimiquimodLeishmania mexicanaLeishmaniosisLutzomyiasand flies

Identifiers

PMID33815814
PMCPMC7995465
OpenAlexW3138238490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.